Thomas J. Schuetz

2022

In 2022, Thomas J. Schuetz earned a total compensation of $2.1M as President of Research & Development formerly CEO at Compass Therapeutics, a 60% decrease compared to previous year.

Compensation breakdown

Bonus$275,000
Option Awards$1,285,628
Salary$550,000
Other$4,557
Total$2,115,185

Schuetz received $1.3M in option awards, accounting for 61% of the total pay in 2022.

Schuetz also received $275K in bonus, $550K in salary and $4.6K in other compensation.

Rankings

In 2022, Thomas J. Schuetz's compensation ranked 1,680th out of 5,672 executives tracked by ExecPay. In other words, Schuetz earned more than 70.4% of executives.

ClassificationRankingPercentile
All
1,680
out of 5,672
70th
Division
Manufacturing
873
out of 3,081
72nd
Major group
Chemicals And Allied Products
347
out of 1,396
75th
Industry group
Drugs
320
out of 1,297
75th
Industry
Biological Products, Except Diagnostic Substances
80
out of 295
73rd
Source: SEC filing on April 29, 2024.

Schuetz's colleagues

We found one more compensation record of an executive who worked with Thomas J. Schuetz at Compass Therapeutics in 2022.

2022

Vered Bisker-Leib

Compass Therapeutics

Chief Executive Officer

News

In-depth

You may also like